FluoroPharma Medical Inc Sustainability Reports
FluoroPharma Medical, Inc. is a biopharmaceutical enterprise engaged in the discovery, development, and commercialization of molecular positron emission tomography (PET) imaging radiopharmaceuticals, primarily targeting the detection of cardiovascular diseases.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG001SNZ604
1 reports from 2016 to 2016
Company Profile
FluoroPharma Medical, Inc. is a biopharmaceutical enterprise engaged in the discovery, development, and commercialization of molecular positron emission tomography (PET) imaging radiopharmaceuticals, primarily targeting the detection of cardiovascular diseases.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
